Eight international projects test AI’s clinical impact

November 18, 2026
Eight international projects test AI’s clinical impact
AI
News

Artificial intelligence is rapidly entering hospitals, clinics and public health services, but evidence of its impact on patient outcomes and healthcare delivery remains uneven. A new international research initiative led by the American Institutes for Research aims to address that gap through eight projects examining AI applications in real-world healthcare settings, including cancer treatment, emergency care, vision services and HIV prevention.

The American Institutes for Research (AIR) has launched an international research network to investigate a question that is becoming increasingly important for healthcare organisations investing in artificial intelligence: does the technology actually improve care when introduced into everyday clinical practice?

Announced on 17 November, the AI in Health Network brings together researchers, healthcare organisations and technology developers to examine the benefits, risks and practical applications of AI across eight selected projects. Rather than concentrating exclusively on algorithm performance, the initiative is designed to generate evidence about how AI functions in healthcare delivery and what difference it can make for patients and health systems.

The research covers several areas in which healthcare organisations are already exploring AI-supported services. These include improving cancer treatment, reducing waiting times in emergency departments, expanding access to vision care, supporting HIV prevention and strengthening nutrition services. Although the clinical settings differ considerably, the projects share a common objective: understanding whether AI can deliver meaningful improvements under the operational conditions in which healthcare professionals actually work.

Moving beyond technical performance

The initiative addresses a persistent weakness in healthcare AI development. Many systems demonstrate promising results during retrospective evaluations or controlled research, but their performance in everyday clinical environments can be substantially more difficult to establish.

An algorithm may identify abnormalities in medical images with high accuracy, for example, without necessarily improving the speed of diagnosis or changing treatment decisions. Similarly, an AI system designed to predict emergency department demand may generate useful forecasts while delivering limited operational value if hospitals lack the staffing flexibility or organisational processes needed to act on them.

These distinctions matter because healthcare organisations are increasingly expected to justify technology investments through measurable improvements in quality, accessibility, efficiency and patient outcomes. Technical accuracy is important, but it is only one component of clinical effectiveness.

AIR's research programme is intended to examine AI applications in real-world settings, where factors such as workflow integration, professional acceptance, patient characteristics and available resources influence whether an intervention succeeds. The eight projects are expected to contribute evidence that can inform decisions about where AI should be deployed and under what conditions.

The range of applications is particularly relevant. In cancer care, AI may support clinical assessment or treatment-related decisions, but any improvement must ultimately be evaluated against meaningful clinical measures. In emergency departments, technology intended to reduce waiting times must be considered alongside patient flow, staffing, bed availability and the wider hospital system. Applications targeting vision care or HIV prevention raise additional questions about accessibility, equity and whether digital tools can reach populations that existing services struggle to support.

These are different implementation challenges, and the research network does not assume that one approach will work equally well across all of them.

Evidence that healthcare organisations can use

The international character of the network is important because healthcare AI does not operate independently of the system in which it is introduced. Differences in clinical practice, digital infrastructure, regulation, workforce capacity and patient populations can affect both the performance and the usefulness of a technology.

A system that works in a highly digitised hospital may be difficult to reproduce in a smaller facility with fragmented records or limited technical support. An application that improves access in one healthcare system may encounter entirely different barriers elsewhere.

Research conducted across different clinical and organisational environments can help identify which benefits are attributable to the technology itself and which depend on the surrounding conditions.

For hospital leaders and policymakers, that distinction has practical consequences. Decisions about AI procurement and implementation require more than evidence that a model performs well on a benchmark. They also require an understanding of the resources needed for deployment, the responsibilities of healthcare professionals, the risks introduced by automation and the indicators that should be monitored after implementation.

The AIR initiative could contribute to that evidence base by examining applications across several areas of healthcare rather than treating AI as a single intervention. However, the network has only just been launched. The announcement establishes the research agenda; it does not demonstrate that the selected technologies have already improved clinical outcomes or reduced healthcare costs.

The value of the programme will therefore depend on the quality of the individual evaluations, the transparency of the methods and the extent to which findings can be applied beyond the participating organisations.

From experimentation to accountability

Healthcare AI is entering a phase in which implementation decisions increasingly require evidence of real-world value. The number of available tools continues to expand, but healthcare organisations must determine which applications deserve investment, how they should be evaluated and when their use should be reconsidered.

That requires a broader approach to innovation than developing and testing algorithms in isolation. Clinical outcomes, workflow changes, patient experience, safety and the distribution of benefits across different populations all need to be considered.

The newly established AI in Health Network reflects that shift in emphasis. Its eight projects will examine technologies in different clinical contexts, creating an opportunity to investigate not only whether AI can perform a task, but whether its introduction improves the delivery of healthcare.

For an international healthcare sector facing workforce shortages, growing demand and increasing pressure on resources, that is an essential distinction. The next stage of AI adoption will depend less on the number of promising demonstrations and more on the availability of reliable evidence showing where these systems make a measurable difference.

Add ICT&health on Google

Show more content from ICT&health in Google Search.

Add on Google

This topic will also have a prominent place at the ICT&health World Conference 2027. Want to be there and stay ahead of what’s next in healthcare? Reserve your ticket today.